Valeant raises Allergan offer for second time in three days
Valeant Pharmaceuticals International has taken the unusual step of upping its unsolicited bid to buy Allergan for the second time in a few days.
Read MoreAuthor: Kevin Grogan
Bayer gets Europe OK for Nexavar in thyroid cancer
The European Commission has expanded the approved uses of Bayer and Amgen unit Onyx Pharmaceuticals’ Nexavar to treat the most common form of thyroid cancer.
Read MoreHealth services should be small and local: NHS chief Stevens
Simon Stevens, the new chief executive of NHS England, says the service needs to return to treating more patients in their local communities, and learn from countries such as Sweden, Holland and the USA to bolster care around small hospitals.
Read MoreItaly’s Newron files Parkinson’s drug with FDA
Newron Pharmaceuticals and fellow Italy-headquartered partner Zambon have filed their investigational Parkinson’s disease treatment safinamide with regulators in the USA.
Read MorePharma miles behind on multichannel marketing
The pharmaceutical industry is miles behind European healthcare professionals and patients when it comes to multichannel marketing, according to a report.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
